• Home »
• Research and Technology »
• Clinical Research »
• Open Trials

Open Trials

Gastrointestinal

RTOG 0436 A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin, and Radiation for Patients with Esophageal Cancer who are treated without surgery ON HOLD

Prostate

RTOG 0815 A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short- Term androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer

COMING SOON: UPCI 09-031 Prospective Evaluation of Hypofractionated Stereotactic Body Radiotherapy for low and intermediate risk prostate cancer

Lung

RTOG 0617 A randomized Phase III comparison of Standard-Dose vs. High-Dose Radiotherapy with concurrent and consolidation Carbo/Paclitaxel +/- cetuximab in patients with Stage IIIa/B NSCLC
Arms B & D Closed

ECOG 1505 A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB-IIA NSCLC

ECOG 5508 Randomized Phase III Study of Maintenance Therapy with Bevacizumab, Pemetrexed, or a Combination of Bevaciaumab and Pemetrexed Following Carboplatin, Paclitaxel and Bevacizumab for Advanced NSCLC

Head/Neck

RTOG 0920 A Phase III study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for locally Advanced Resected Head and Neck Cancer

Breast

NSABP B 43 A Phase III Clinical Trial Comparing Trastuzumab Given Concurrently with Radiation Therapy and Radiation Therapy Alone for Women with HER2-Positive Ductal Carcinoma In Situ Resected by Lumpectomy

CALGB 40601 Randomized Phase III Trial of Paclitaxel combined with Trastuzumab, Lapatinib, or Both as Neoadjuvant Treatment of Her2-Pos primary Breast Cancer

Brain Metastases

RTOG 0933 A Phase II Trial of Hippocampal Avoidance during Whole Brain Radiotherapy for Brain Metastases

Diagnostic

ACRIN (American College of Radiology Imaging Network) NOPR Trial Sodium Floride- Bone Mets

ACRIN (American College of Radiology Imaging Network) NOPR Trial The National Oncologic PET Registry—Center for Medicare and Medicaid Services to expand coverage for PET emission tomography to include cancer indications not currently covered

Director of
Clinical Research:

Raymond B. Wynn, MD, FACR

Research Coordinator:

Mary Lynn Haynes RN, OCN Telephone: (814) 838-0448

More detailed information about any specific trial may be available on the cooperative group website:

• RTOG - Radiation Therapy Oncology Group
• NSABP - National Surgical Adjuvant Breast and Bowel Project
• CTSU - Cancer Trials Support Unit
• ECOG - Eastern Cooperative Oncology Group